DENTSPLY SIRONA Inc. (XRAY) financials: revenue, earnings and cash flow
Fiscal 2016–2025 + TTM · from SEC filings · data as of November 13, 2026
Summary
DENTSPLY SIRONA’s revenue went from $3.7B in fiscal 2016 to $3.7B in fiscal 2025, a decline of about 0.2% a year.
Net income in fiscal 2025 was -$598M, a net margin of -16.2%; the best year in this period was 2016 with $430M.
Over the twelve months to September 30, 2026, revenue was $3.6B and net income -$121M.
Free cash flow was $104M in fiscal 2025 and positive in 10 of the 10 years shown.
The diluted share count fell 10% over the period (buybacks).
Revenue, profit and cash flow by year
Income statement
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.6B | $3.7B | $3.8B | $4.0B | $3.9B | $4.2B | $3.3B | $4.0B | $4.0B | $4.0B | $3.7B |
| Gross profit | $1.8B | $1.8B | $2.0B | $2.1B | $2.1B | $2.3B | $1.7B | $2.2B | $2.1B | $2.2B | $2.0B |
| Operating income | -$55M | -$422M | -$879M | -$85M | -$937M | $608M | -$3M | $353M | -$958M | -$1.6B | $455M |
| Net income | -$121M | -$598M | -$910M | -$132M | -$950M | $411M | -$73M | $256M | -$1.0B | -$1.6B | $430M |
| EPS (diluted) | $-0.61 | $-3.00 | $-4.48 | $-0.62 | $-4.41 | $1.87 | $-0.33 | $1.14 | $-4.51 | $-6.76 | $1.94 |
| R&D | $171M | $150M | $165M | $184M | $174M | $171M | $123M | $143M | $161M | $152M | $128M |
| Revenue growth | — | −3.0% | −4.3% | +1.1% | −7.3% | +26.7% | −17.0% | +0.9% | −0.2% | +6.6% | +40.1% |
Cash flow
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $272M | $235M | $461M | $377M | $517M | $657M | $649M | $639M | $500M | $602M | $563M |
| Capital spending | -$169M | -$131M | -$180M | -$149M | -$149M | -$142M | -$87M | -$123M | -$183M | -$144M | -$125M |
| Free cash flow | $103M | $104M | $281M | $228M | $368M | $515M | $562M | $516M | $317M | $458M | $438M |
| Dividends paid | $64M | $128M | $126M | $116M | $104M | $92M | $88M | $81M | $79M | $78M | $65M |
| Buybacks | $25M | $0 | $250M | $300M | $150M | $200M | $140M | $260M | $250M | $401M | $814M |
| Stock-based pay | $33M | $33M | $39M | $46M | $59M | $48M | $47M | $66M | $21M | $48M | $41M |
Balance sheet
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash | — | $326M | $272M | $334M | $365M | $339M | $438M | $405M | $310M | $321M | $384M |
| Debt | — | $2.4B | $1.9B | $2.1B | $2.1B | $2.1B | $2.5B | $1.6B | $1.6B | $1.6B | $1.5B |
| Equity | — | $1.3B | $1.9B | $3.3B | $3.8B | $5.0B | $4.9B | $5.1B | $5.1B | $6.6B | $8.1B |
| Total assets | — | $5.4B | $5.8B | $7.4B | $7.6B | $9.2B | $9.3B | $8.6B | $8.7B | $10.4B | $11.6B |
| Shares (diluted) | 199M | 199M | 203M | 212M | 216M | 220M | 219M | 224M | 224M | 229M | 222M |
Margins and returns
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 50.5% | 50.0% | 51.6% | 52.6% | 54.2% | 55.5% | 49.6% | 53.8% | 51.9% | 54.8% | 53.4% |
| Operating margin | -1.5% | -11.5% | -23.2% | -2.1% | -23.9% | 14.4% | -0.1% | 8.8% | -24.0% | -39.1% | 12.1% |
| Net margin | -3.4% | -16.2% | -24.0% | -3.3% | -24.2% | 9.7% | -2.2% | 6.4% | -25.4% | -38.8% | 11.5% |
| FCF margin | 2.9% | 2.8% | 7.4% | 5.8% | 9.4% | 12.2% | 16.8% | 12.8% | 8.0% | 11.5% | 11.7% |
| ROIC | — | -8.9% | -22.3% | -1.2% | -14.3% | 6.4% | -0.0% | 4.0% | -11.3% | -18.3% | 4.6% |
| ROE | — | -44.7% | -46.9% | -4.0% | -24.9% | 8.2% | -1.5% | 5.0% | -19.7% | -23.4% | 5.3% |
Frequently asked questions
What is DENTSPLY SIRONA’s annual revenue?
$3.7B in fiscal 2025 and $3.6B over the twelve months to September 30, 2026.
How much profit does DENTSPLY SIRONA make?
Net income was -$598M in fiscal 2025 (net margin -16.2%).
Is DENTSPLY SIRONA’s revenue growing?
No: revenue fell 3.0% in fiscal 2025 compared with the year before.
From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.